Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanogen

This article was originally published in The Gray Sheet

Executive Summary

Raises $3.5 mil. in first round of venture capital financing to fund development of DNA-based diagnostic tests using "ultraminiaturized silicon chips inlaid with artificial DNA to detect specific gene sequences," the firm says in a March 15 release. Investors include Enterprise Partners, Kleiner Perkins Caufield & Byers and Nanogen Chairman and CEO Howard Birndorf, who have "committed to additional funding as the company reaches certain milestones," the firm says.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel